Literature DB >> 9459120

Establishment of a new murine-phenotypic angiosarcoma cell line (ISOS-1).

M Masuzawa1, T Fujimura, M Tsubokawa, S Nishiyama, K Katsuoka, E Terada, S Kunita, Y Sakurai, H Kato.   

Abstract

A cell line, designated ISOS-1, was established from a tumor formed by transplantation of a human angiosarcoma into mice with severe combined immunodeficiency (SCID). The cells showed endothelial properties, based on the uptake of Dil-Ac-LDL and binding of UEA-I/GSA-I lectins, but were negative for CD11b and Pan Cytokeratin. However, the cells lost differentiated characteristics such as expression of von Willebrand factor, contact inhibition growth and tube formation activity. These findings indicate that ISOS-1 is a poorly-differentiated endothelial cell line. At the 81st passage, all of the cells were positive for H-2Dd in various intensity, but not HLA-ABC. The metaphase chromosomes consistently showed a characteristic mouse, but not human, telocentric form. Furthermore, this cell line produced fatal tumor growth in SCID mice and also in BALB/c mice. These results suggest that ISOS-1 is a murine-phenotypic angiosarcoma cell line.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9459120     DOI: 10.1016/s0923-1811(97)00032-7

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  10 in total

1.  Infiltration of PD-1-positive cells in combination with tumor site PD-L1 expression is a positive prognostic factor in cutaneous angiosarcoma.

Authors:  Yuki Honda; Atsushi Otsuka; Sachiko Ono; Yosuke Yamamoto; Judith A Seidel; Satoshi Morita; Masahiro Hirata; Tatsuki R Kataoka; Tatsuya Takenouchi; Kazuyasu Fujii; Takuro Kanekura; Yuko Okubo; Kenzo Takahashi; Teruki Yanagi; Daichi Hoshina; Hiroo Hata; Riichiro Abe; Taku Fujimura; Takeru Funakoshi; Koji Yoshino; Mamiko Masuzawa; Yasuyuki Amoh; Ryota Tanaka; Yasuhiro Fujisawa; Tetsuya Honda; Kenji Kabashima
Journal:  Oncoimmunology       Date:  2016-11-04       Impact factor: 8.110

2.  Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression.

Authors:  David Sánchez-Martín; Atsushi Otsuka; Kenji Kabashima; Taekyu Ha; Dunrui Wang; Xiaolan Qian; Douglas R Lowy; Giovanna Tosato
Journal:  J Natl Cancer Inst       Date:  2018-04-01       Impact factor: 13.506

3.  Generation of a murine hepatic angiosarcoma cell line and reproducible mouse tumor model.

Authors:  Sonja Rothweiler; Michael T Dill; Luigi Terracciano; Zuzanna Makowska; Luca Quagliata; Ruslan Hlushchuk; Valentin Djonov; Markus H Heim; David Semela
Journal:  Lab Invest       Date:  2014-11-24       Impact factor: 5.662

4.  Loss of autocrine endothelial-derived VEGF significantly reduces hemangiosarcoma development in conditional p53-deficient mice.

Authors:  Morvarid Farhang Ghahremani; Enrico Radaelli; Katharina Haigh; Sonia Bartunkova; Lieven Haenebalcke; Jean-Christophe Marine; Steven Goossens; Jody J Haigh
Journal:  Cell Cycle       Date:  2014-03-11       Impact factor: 4.534

5.  DLC1 deficiency and YAP signaling drive endothelial cell contact inhibition of growth and tumorigenesis.

Authors:  Lisa Ritchey; Taekyu Ha; Atsushi Otsuka; Kenji Kabashima; Dunrui Wang; Yuyi Wang; Douglas R Lowy; Giovanna Tosato
Journal:  Oncogene       Date:  2019-08-13       Impact factor: 9.867

6.  Strong radioprotective FGF1 signaling down-regulates proliferative and metastatic capabilities of the angiosarcoma cell line, ISOS-1, through the dual inhibition of EGFR and VEGFR pathways.

Authors:  Taichi Miura; Mayumi Fujita; Mitsuko Kawano; Kaori Imadome; Takeshi Yasuda; Shoko Nishihara; Toru Imamura; Mikio Masuzawa; Takashi Imai; Fumiaki Nakayama
Journal:  Clin Transl Radiat Oncol       Date:  2017-11-04

7.  Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma.

Authors:  Clarissa N Amaya; Mariah Perkins; Andres Belmont; Connie Herrera; Arezo Nasrazadani; Alejandro Vargas; Thuraieh Khayou; Alexa Montoya; Yessenia Ballou; Dana Galvan; Alexandria Rivas; Steven Rains; Luv Patel; Vanessa Ortega; Christopher Lopez; William Chow; Erin B Dickerson; Brad A Bryan
Journal:  Oncoscience       Date:  2018-04-29

8.  Hemangiosarcoma cells induce M2 polarization and PD-L1 expression in macrophages.

Authors:  Kevin Christian M Gulay; Keisuke Aoshima; Naoya Maekawa; Tamami Suzuki; Satoru Konnai; Atsushi Kobayashi; Takashi Kimura
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.379

9.  Establishment and characterization of a novel lymphangiosarcoma cell line (MO-LAS) compared with the hemangiosarcoma cell line (ISO-HAS).

Authors:  Mikio Masuzawa; Mamiko Masuzawa; Yuhko Hamada; Nobuko Arakawa; Mari Mori; Masako Ishii; Shigeo Nishiyama
Journal:  Cancer Med       Date:  2012-07-13       Impact factor: 4.452

10.  Extracellular matrix composition modulates angiosarcoma cell attachment and proliferation.

Authors:  Noel L Shaheen; Esha Kataria; Jocelyn Antony; Dana Galvan; Yessenia Ballou; Brad A Bryan
Journal:  Oncoscience       Date:  2017-12-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.